← Leaderboards
George A. Oyler
University Of Maryland Baltimore
$2,873,004
Attributed
$4,912,084
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $860.4K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,912,084 · 3
By mechanism
R01$4,540,834 · 2
R21$371,250 · 1
Top collaborators
- Charles Bix Shoemaker5 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- James P. Nataro$22,975,369
- Junfang Wu$12,285,191
- Ashiwel S Undieh$4,160,039
- Jennifer Snyder$7,246,584
Others in their field
Top investigators on “Enzyme Activity”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$47,808,754
- Susan Abushakra · Alzheon, Inc.$47,265,244
- David Heimbrook · Leidos Biomedical Research, Inc.$45,964,082
- Stuart L Schreiber · Harvard University (Medical School)$40,631,496
- Keith O Hodgson · Stanford University$37,935,767
Research focus
Enzyme ActivityNeuronsMutantAnimal ModelBinding (Molecular Function)Animal TestingDrug DevelopmentAnimalsBloodBaseBotulinum Toxin Type ABotulinum Toxin Type BBotulinum Toxin Type CBotulismCellsCategoriesCenters For Disease Control And Prevention (U.S.)AntidotesClostridium BotulinumClostridium DifficileBontoxilysinCytosolDesignBiodefense
Grant awards (8)
A platform for therapeutic agents that promote rapid recovery from botulism$859,639
R01 · FY2015 · AI
A platform for therapeutic agents that promote rapid recovery from botulism$785,489
R01 · FY2014 · AI
A platform for therapeutic agents that promote rapid recovery from botulism$738,360
R01 · FY2013 · AI
A platform for therapeutic agents that promote rapid recovery from botulism$834,310
R01 · FY2012 · AI
A platform for therapeutic agents that promote rapid recovery from botulism$860,362
R01 · FY2011 · AI
High Throughput Screens for Botulinum Toxin Therapeutics$462,674
R01 · FY2005 · AI
Neuroprotective Mechanisms of Parkin$185,625
R21 · FY2003 · NS
Neuroprotective Mechanisms of Parkin$185,625
R21 · FY2002 · NS